США - англійська - NLM (National Library of Medicine)

puracap laboratories, llc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol is a bile acid available as 300 mg capsules suitable for oral administration. ursodiol, usp (ursodeoxycholic acid), is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. it is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. the chemical name for ursodiol is 3α, 7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol, usp has a molecular weight of 392.57. its structure is shown below: inactive ingredients : corn starch, magnesium stearate, silicon dioxide and the capsule shell contain the following ingredients, gelatin, titanium dioxide, d&c red # 28, fd&c blue # 1 and fd&c red # 40. the imprinting ink contains the following: black iron oxide, d&c yellow # 10 aluminum lake, fd&c blue # 1 aluminum lake, fd&c blue # 2 aluminum lake, fd&c red # 40 aluminum lake, propylene glycol and shellac glaze.

США - англійська - NLM (National Library of Medicine)

major pharmaceuticals - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol is a bile acid available as 300 mg capsules suitable for oral administration. ursodiol (ursodeoxycholic acid), is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. ursodiol, usp is a white or almost white crystalline powder, practically insoluble in water, freely soluble in ethanol (96%), slightly soluble in acetone and practically insoluble in methylene chloride. the chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol, usp has a molecular weight of 392.6 g/mol. its structure is shown below: inactive ingredients : colloidal silicon dioxide, gelatin, iron oxide red, magnesium stearate, starch (biological source: maize), titanium dioxide and water. each capsule is imprinted with black pharmaceutical ink which contains butyl alcohol, dehydrated alcohol, ferrosoferric oxide, isopropyl alcohol, purified water, potassium hydroxide, propylene glycol, shellac and strong ammonia solution.

США - англійська - NLM (National Library of Medicine)

vgyaan pharmaceuticals llc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - - ursodiol capsules are indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of ursodiol capsules beyond 24 months is not established. - ursodiol capsules are indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - ursodiol capsules will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for ursodiol capsules therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for ursodiol capsules therapy. - allergy to bile aci

США - англійська - NLM (National Library of Medicine)

aurobindo pharma limited - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - - ursodiol capsules are indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of ursodiol capsules beyond 24 months is not established. - ursodiol capsules are indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - ursodiol capsules will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for ursodiol capsules therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for ursodiol capsules therapy. - allergy to bile aci

США - англійська - NLM (National Library of Medicine)

chartwell rx, llc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - - ursodiol capsules are indicated for patients with radiolucent, noncalcified gallbladder stones <20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of ursodiol beyond 24 months is not established. - ursodiol capsules are indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - ursodiol will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for ursodiol therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for ursodiol therapy. - allergy to bile acids.

США - англійська - NLM (National Library of Medicine)

golden state medical supply, inc. - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - - ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of ursodiol beyond 24 months is not established. - ursodiol is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - ursodiol will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for ursodiol therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for ursodiol therapy. - allergy to bile acids.

США - англійська - NLM (National Library of Medicine)

avkare - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - - ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of ursodiol beyond 24 months is not established. - ursodiol is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - ursodiol will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for ursodiol therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for ursodiol therapy. - allergy to bile acids.

США - англійська - NLM (National Library of Medicine)

actavis pharma, inc. - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol 250 mg

США - англійська - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol 500 mg

США - англійська - NLM (National Library of Medicine)

nexgen pharma, inc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol is a bile acid available as 200 mg and 400 mg capsules suitable for oral administration. ursodiol (ursodesoxycholic acid), is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. it is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. the chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol has a molecular weight of 392.57. its structure is shown below: inactive ingredients: silicon dioxide, magnesium stearate, and corn starch. gelatin capsules contain gelatin and titanium dioxide and are printed with edible black ink; additionally, the 400 mg capsule also contains fd&c yellow #6 and d&c yellow #10.